Sintx Technologies, Inc. (SINT)
Automate Your Wheel Strategy on SINT
With Tiblio's Option Bot, you can configure your own wheel strategy including SINT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol SINT
- Rev/Share 1.4492
- Book/Share 3.4365
- PB 0.905
- Debt/Equity 0.5753
- CurrentRatio 3.445
- ROIC -1.3371
- MktCap 7802088.0
- FreeCF/Share -4.3915
- PFCF -1.0022
- PE -0.4435
- Debt/Assets 0.3061
- DivYield 0
- ROE -2.0366
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market
Published: May 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
SALT LAKE CITY, Utah, May 22, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced ceramics for medical device and other technical applications, announced the issuance of International Patent No. 7635292, which covers novel agricultural uses of the Company's silicon nitride (Si₃N₄) particularly in plant protection and antimicrobial treatment. This patent, combined with issued U.S. Patent No. 11,591,217, creates a family of patents focused on addressing the antimicrobial agribiotech market.
Read More
SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules
Published: February 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
Salt Lake City, Utah, Feb. 26, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc., (“SINTX” or the “Company”) (Nasdaq: SINT), a leader in advanced ceramics for medical applications, today announced that it has, pursuant to a securities purchase agreement with institutional and accredited investors dated February 20, 2025, issued and sold 1,449,287 shares of common stock (or pre-funded warrants in lieu therof) at a purchase price of $3.45 per share (or pre-funded warrant in lieu thereof) in a private placement priced at-the-market under Nasdaq rules. In addition, the Company issued to the investors in the offering unregistered warrants (the “warrants”) to …
Read More
SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial
Published: February 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
Salt Lake City, Utah, Feb. 19, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) an advanced ceramics company specializing in the development and commercialization of materials, components, and technologies for medical and technical applications, today announced the issuance of U.S. Patent No. 12,239,761 by the United States Patent and Trademark Office (USPTO).
Read More
About Sintx Technologies, Inc. (SINT)
- IPO Date 2014-02-13
- Website https://www.sintx.com
- Industry Medical - Devices
- CEO Eric K. Olson
- Employees 20